Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: Safety and feasibility in the era of escalating drug resistance

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 3, 2009, Pages 253-259

  Ghannam, D E ^a   Rodriguez, G H ^a   Raad, I I ^a   Safdar, A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ADULT; APNEA; ARTICLE; BRONCHOSPASM; CANCER PATIENT; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; KIDNEY DYSFUNCTION; MALE; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, INHALATION; ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COLISTIN; CRITICAL ILLNESS; DRUG RESISTANCE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; NEOPLASMS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEROIDS; TREATMENT OUTCOME;

EID: 61349147751     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0620-5     Document Type: Article

References (30)

1. A Safdar D Armstrong 2001 Infectious morbidity in critically ill patients with cancer Crit Care Clin 17 531 570
2. American Thoracic Society and Infectious Diseases Society of America 2005 Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 388 416
3. National Nosocomial Infections Surveillance (NNIS) 1999 System report, data summary from January 1990-May 1999, issued June 1999 Am J Infect Control 27 520 532
4. I Porzecanski DL Bowton 2006 Diagnosis and treatment of ventilator-associated pneumonia Chest 130 597 604
5. KA Davis 2006 Ventilator-associated pneumonia: a review J Intensive Care Med 21 211 216
6. S Kiem JJ Schentag 2006 Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia Semin Respir Crit Care Med 27 51 67
7. C Brun-Buisson F Lemaire 2001 Administration of antibiotics for pneumonia during respiratory failure: reaching the target Am J Respir Crit Care Med 164 1554 1555
8. M Schmidt-loanas A de Roux H Lode 2005 New antibiotics for the treatment of severe staphylococcal infection in the critically ill patients Curr Opin Crit Care 11 481 486
9. R Canton N Cobos J de Gracia F Baquero J Honorato S Gartner 2005 Antimicrobial therapy for pulmonary pathogenic colonization and infection by Pseudomonas aeruginosa in cystic fibrosis patients Clin Microbiol Infect 11 690 703
10. RB Brown JA Kruse GW Counts JA Russell NV Christou ML Sands 2005 Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia Antimicrob Agents Chemother 34 269 272
11. AL Kwa C Loh JG Low A Kurup VH Tam 2005 Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa Clin Infect Dis 41 754 757
12. DH Hamer 2000 Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin Am J Respir Crit Care Med 162 328 330
13. A Michalopoulos SK Kasiakou Z Mastora K Rellos AM Kapaskelis ME Falagas 2005 Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis Crit Care 9 R53 R59
14. CM Luna D Blanzaco MS Niederman W Matarucco NC Baredes P Desmery 2003 Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome Crit Care Med 31 676 682
15. WR Jarvis JR Edwards DH Culver JM Hughes T Horan TG Emori 1991 Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System Am J Med 91 185 191
16. DJ Conrad 2003 The clinical use of aerosolized antibiotics Clin Pulm Med 10 201 207
17. LB Palmer GC Smaldone SR Simon TG O'Riordan A Cuccia 1998 Aerosolized antibiotics in mechanically ventilated patients: delivery and response Crit Care Med 26 31 39
18. I Goldstein J Chastre JJ Rouby 2006 Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents Semin Respir Crit Care Med 27 82 91
19. DE Geller WH Pitlick PA Nardella WG Tracewell BW Ramsey 2002 Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis Chest 122 219 226
20. HD Fuller MB Dolovich G Posmituck WW Pack MT Newhouse 1989 Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients Am Rev Respir Dis 141 440 444
21. NR MacIntyre RM Silver CW Miller F Schuler RE Colman 1985 Aerosol delivery to intubated, mechanically ventilated patients Crit Care Med 13 81 84
22. LB Palmer GC Smaldone S Simon T O'Riordan L Morra 1995 Tracheal aspirate in long-term mechanically ventilated patients. A human model of gram-negative infection and airway inflammation Chest 108 1326 1332
23. JS Ilowite JD Gorvoy GC Smaldone 1987 Quantitative deposition of aerosolized gentamicin in cystic fibrosis Am Rev Respir Dis 136 1445 1449
24. GC Smaldone JT Fuhrer RT Steigbigel M McPeck 1991 Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection Am Rev Respir Dis 143 727 737
25. ME Drobnic P Sune JB Montoro A Ferrer R Orriols 2005 Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa Ann Pharmacother 39 39 44
26. P Linden DL Paterson 2006 Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia Clin Infect Dis 43 S89 S94
27. P Le Conte G Potel P Peltier D Horeau J Caillon ME Juvin 1993 Lung distribution and pharmacokinetics of aerosolized tobramycin Am Rev Respir Dis 147 1279 1282
28. CG Adair SP Gorman FB O'Neill B McClurg EC Goldsmith CH Webb 1993 Selective decontamination of the digestive tract (SDD) does not prevent the formation of microbial biofilms on endotracheal tubes J Antimicrob Chemother 31 689 697
29. CG Adair SP Gorman LM Byers DS Jones B Feron M Crowe 2002 Eradication of endotracheal tube biofilm by nebulised gentamicin Intensive Care Med 28 426 431
30. E Lesho 2005 Role of inhaled antibacterials in hospital-acquired and ventilator-associated pneumonia Expert Rev Anti Infect Ther 3 445 451